Nexteligent(OTC) NXGT

Current Price$0.01

Market Cap$822.50K

Since IPO (2018)-96%

5 Year-93%

1 Year-35%

1 Month+0%

Nexteligent last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-07-23

Nexteligent stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.01	2026-07-14
1 month	+0%	USD 0.01	2026-06-16
3 month	+1.56%	USD 0.01	2026-04-24
Year to date	-6.34%	USD 0.01	2025-12-31
1 year	-35%	USD 0.01	2025-07-22
3 year	-30.85%	USD 0.01	2023-07-24
5 year	-92.9%	USD 0.09	2021-07-23
Since inception	-96.39%	USD 0.18	2018-12-07

Nexteligent Financials at a Glance

Market Cap

$822.50K

Revenue (TTM)

$222.44K

Net Income (TTM)

-$87.44K

EPS (TTM)

-$0.00

P/E Ratio

-9.29

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.01

Volume

10,000

Open

$0.01

Price

$0.01

Volume

10,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.01

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.01

Volume

10,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.01

Estimated Earnings Date

N/A

NXGT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexteligent

Nexteligent Holdings, Inc. operates as a key aggregator of healthcare professional services and technology enterprises. The company focuses on providing essential offerings in telemedicine, expert consulting, and financial administration.

Products and Services

Telemedicine Solutions for virtual healthcare initiatives
Expert consulting services for healthcare institutions
Comprehensive revenue cycle management and claim recovery

Growth Outlook

Telemedicine market projected to grow significantly in the coming years
Increased demand for efficient healthcare solutions drives service expansion
Strategic partnerships expected to enhance service offerings and market reach

Financial Highlights

Recent quarterly revenue of 37,701, showing a focus on growth
Trailing twelve months (TTM) P/E ratio of 9.29 indicates potential value
Operating cash flow improved, reflecting better financial management

Nexteligent Holdings, Inc. is positioned within the healthcare sector, specifically focusing on enhancing operational efficiency and patient care through innovative solutions. The company's commitment to telemedicine and financial services aligns with the growing demand for accessible healthcare, particularly in the eldercare sector. Recent financial data indicates a focus on improving revenue streams and managing operational costs effectively. The company's strategic initiatives and market positioning suggest a potential for growth in a rapidly evolving healthcare landscape.

AI Generated • Jul 16, 2026

Industry

Professional Services

Sector

Industrials

Employees

CEO

Paul Cristiano

Website

www.nexteligent.com

Headquarters

Avon, CT 06001, US

NXGT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

-0.55%

Net Income Margin

-39.31%

Return on Equity

3.23%

Return on Capital

N/A

Return on Assets

-20.33%

Earnings Yield

-10.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$822.50K

Shares Outstanding

126.54M

Volume

10.00K

Avg. Volume

4.13K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.23K

EBITDA

-$1.23K

Operating Cash Flow

-$65.35K

Capital Expenditure

-$3.00

Free Cash Flow

-$65.36K

Cash & ST Invst.

$160.00

Total Debt

$1.69M

Nexteligent Performance Analysis

Nexteligent annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 490,561	-39.1%
2023	2023-12-31	USD 351,663	-28.3%
2024	2024-12-31	USD 214,258	-39.1%
2025	2025-12-31	USD 255,271	19.1%

Nexteligent sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	5.5%
Q3	2025-09-30	-15.6%
Q4	2025-12-31	-24.3%
Q1	2026-03-31	-20.7%

Nexteligent annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	-30.0%
2023	2023-12-31	USD -0.00	257.1%
2024	2024-12-31	USD -0.00	-20.0%
2025	2025-12-31	USD -0.00	-65.0%

Nexteligent sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	200.0%
Q3	2025-09-30	N/A
Q4	2025-12-31	-50.0%
Q1	2026-03-31	100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$37.70K

-46.5%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$822.50K

N/A

Market Cap/Employee

$117.50K

N/A

Employees

N/A

Net Income

-$25.91K

-0.3%

EBITDA

-$5.80K

-78.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$160.00

-94.1%

Total Debt

$1.69M

-22.3%

Accounts Receivable

$44.02K

+18.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.69M

-22.3%

Return on Assets

-20.33%

N/A

Return on Invested Capital

0.07%

N/A

Free Cash Flow

-$5.93K

-169.8%

Operating Cash Flow

-$5.93K

-169.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VDRMViaDerma, Inc.

VDRMViaDerma, Inc.$0.00+0.00%

FORZForza Innovations Inc.

FORZForza Innovations Inc.$0.00+0.00%

BSYIBioSyntech, Inc.

BSYIBioSyntech, Inc.$0.00+0.00%

GSACGelStat Corporation

GSACGelStat Corporation$0.00+0.00%

EMDFGarrison Film Productions Inc.

EMDFGarrison Film Productions Inc.$0.00+0.00%

DRWNQuantum Medical Transport, Inc.

DRWNQuantum Medical Transport, Inc.$0.00+0.00%

FFNTF4Front Ventures Corp.

FFNTF4Front Ventures Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

TAT&T

TAT&T$24.13+0.05%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About NXGT

What is the current price of Nexteligent?

Nexteligent is trading at $0.01 per share.

What is the 52-week range for Nexteligent?

Over the past 52 weeks, Nexteligent has traded between $0.01 and $0.01.

How much debt does Nexteligent have?

As of the most recent reporting period, Nexteligent reported total debt of $1.69M.

How much cash does Nexteligent have on hand?

Nexteligent reported $160.00 in cash and cash equivalents in its most recent financial results.

What is Nexteligent’s dividend yield?

Nexteligent does not currently have a dividend yield.

Nexteligent(OTC) NXGT

Nexteligent Financials at a Glance

NXGT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nexteligent

NXGT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nexteligent Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NXGT

What is the current price of Nexteligent?

What is the 52-week range for Nexteligent?

How much debt does Nexteligent have?

How much cash does Nexteligent have on hand?

What is Nexteligent’s dividend yield?

Premium Investing Services